Athanasios Skoutelis
Overview
Explore the profile of Athanasios Skoutelis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
991
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paraskevis D, Gkova M, Mellou K, Gerolymatos G, Psalida N, Gkolfinopoulou K, et al.
J Infect Dis
. 2023 Aug;
228(12):1667-1674.
PMID: 37565522
Background: Using a retrospective cohort study design, we aimed to evaluate the effectiveness of molnupiravir and nirmatrelvir/ritonavir in patients with SARS-CoV-2 who were highly vulnerable. Methods: The impact of each...
2.
Samarkos M, Papanikolaou K, Sourdi A, Paisios N, Mainas E, Paramythiotou E, et al.
Antibiotics (Basel)
. 2022 Aug;
11(8).
PMID: 36009935
(1) Background: It is not known whether different daily dosing schemes have different effects on colistin nephrotoxicity. We examined the effect of once- versus twice- or thrice-daily doses of colistin...
3.
Caby F, Guiguet M, Weiss L, Winston A, Miro J, Konopnicki D, et al.
Clin Infect Dis
. 2021 Aug;
73(1):50-59.
PMID: 34370842
Background: A persistently low CD4/CD8 ratio has been reported to inversely correlate with the risk of non-AIDS defining cancer in people living with human immunodeficiency virus (HIV; PLWH) efficiently treated...
4.
Chorafa E, Iosifidis E, Tsiodras S, Skoutelis A, Kourkouni E, Kopsidas I, et al.
Infect Control Hosp Epidemiol
. 2020 Nov;
42(6):702-709.
PMID: 33198846
Objective: To audit clinical practice and implement an intervention to promote appropriate use of perioperative antimicrobial prophylaxis (PAP). Design: Prospective multicenter before-and-after study. Setting: This study was conducted in 7...
5.
Thompson G, Soriano A, Skoutelis A, Vazquez J, Honore P, Horcajada J, et al.
Clin Infect Dis
. 2020 Sep;
73(11):e3647-e3655.
PMID: 32955088
Background: Rezafungin (RZF) is a novel echinocandin exhibiting distinctive pharmacokinetics/pharmacodynamics. STRIVE was a phase 2, double-blind, randomized trial designed to compare the safety and efficacy of RZF once weekly (QWk)...
6.
Kostaki E, Hodges-Mameletzis I, Magiorkinis G, Adamis G, Xylomenos G, Nikolopoulos G, et al.
Sex Transm Infect
. 2020 Jun;
97(3):232-237.
PMID: 32561553
Objectives: Subtypes A1 and B are the most prevalent HIV-1 clades in Greece. Subtype A1 epidemic is highly monophyletic and corresponds to transmissions that occurred locally. Our aim in this...
7.
Psichogiou M, Giallouros G, Pantavou K, Pavlitina E, Papadopoulou M, Williams L, et al.
AIDS Care
. 2019 Apr;
31(11):1376-1383.
PMID: 30939897
Identifying and linking people to care soon after HIV infection could limit viral transmission and protect their health. This work aims at describing the continuum of care among recently HIV-infected...
8.
Mylona E, Golfinopoulou S, Sfakianaki P, Kyriakopoulos G, Tsonis I, Apostolou T, et al.
Eur J Case Rep Intern Med
. 2019 Feb;
3(5):000424.
PMID: 30755881
Objectives: To report a case of intravascular lymphoma (IVL) in a Caucasian patient who presented with anasarca as his sole clinical sign. Material And Methods: A man presented with anasarca-type...
9.
Vourli G, Nikolopoulos G, Paparizos V, Skoutelis A, Metallidis S, Gargalianos P, et al.
PLoS One
. 2018 Nov;
13(11):e0207355.
PMID: 30440000
Background: Aiming to eliminate HIV infection, UNAIDS has set a global "90-90-90" target by 2020. We sought to construct a 6-stages HIV Cascade of Care (CoC) in Greece, overall and...
10.
Mylona E, Papastamopoulos V, Giannopoulou M, Perivolioti E, Psaroudaki Z, Skoutelis A
Saudi J Kidney Dis Transpl
. 2018 Nov;
29(5):1207-1210.
PMID: 30381521
Cutaneous nocardiosis is an infrequent infection which has been increasingly reported in immunocompromised patients. Although trimethoprim-sulfamethoxazole is considered to be the agent of choice for treatment of nocardiosis, newer antimicrobials...